CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Survey of the Patterns of Using Stereotactic Ablative Radiotherapy for Early-Stage Non-small Cell Lung Cancer in Korea

Sanghyuk Song, Ji Hyun Chang, Hak Jae Kim, Yeon Sil Kim, Jin Hee Kim, Yong Chan Ahn, Jae-Sung Kim, Si Yeol Song, Sung Ho Moon, Moon June Cho, Seon Min Youn

Cancer Research and Treatment. 2017;49(3):688-694. Published online 2016 October 31 DOI: https://doi.org/10.4143/crt.2016.219

171 Stereotactic ablative radiotherapy (SABR) in medically inoperable early stage non-small cell lung cancer (NSCLC): A single tertiary UK centre experience

C. Yip, D.B. Landau, C. Thomas, S. Ahmad

Lung Cancer. 2013;79:S58

Link1 Link2

Stereotactic body radiotherapy for early stage non-small cell lung cancer

F. Lagerwaard

Lung Cancer. 2012;77:S9-S10

Link1 Link2

Outcome of stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCLC)

Mohammad Islam, Abby Cyriac, Tarun Durga, Thomas Sarkodie, Gulshad Begum, Joanne Evans, Sreekanth Palvai, Khin Tun

Lung Cancer. 2023;178:S55

Link1 Link2

Survey of the Patterns of Using Stereotactic Ablative Radiotherapy for Early-Stage Non-small Cell Lung Cancer in Korea

Sanghyuk Song, Ji Hyun Chang, Hak Jae Kim, Yeon Sil Kim, Jin Hee Kim, Yong Chan Ahn, Jae-Sung Kim, Si Yeol Song, Sung Ho Moon, Moon June Cho, Seon Min Youn

Cancer Research and Treatment. 2017;49(3):688-694

Link1

Link2 Link3

Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: Controversies, insights, and changing horizons

Alexander V. Louie, David A. Palma, Max Dahele, George B. Rodrigues, Suresh Senan

Radiotherapy and Oncology. 2015;114(2):138-147

Link1 Link2

Prognostic factors for control of early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy

Thomas Charlton, Sumeet Hindocha, Nikesh Hanumanthappa, Daniel Smith, Sindu Vivekanandan, Benjamin Taylor, Michael Skwarski, Shahreen Ahmad

Lung Cancer. 2021;156:S60-S61

Link1 Link2

Stereotactic ablative radiotherapy (SABR) for early stage, non-small cell lung cancer (NSCLC): two year clinical outcome data from the Oxford Cancer Centre (OCC)

L. Pascal, S. O’Cathail, G. Higgins, D. Ajzensztejn, R. Stuart, N. Panakis

Lung Cancer. 2020;139:S33

Link1 Link2

Proton-Based Stereotactic Ablative Radiotherapy in Early-Stage Non-Small-Cell Lung Cancer

Jonathan D. Grant, Joe Y. Chang

BioMed Research International. 2014;2014:1-7

Link1

Link2 Link3

136: Review of CT imaging following stereotactic ablative radiotherapy for stage 1 non small cell lung cancer

A.C. Pascoe, K. Foweraker, C. Esler, S. Morgan

Lung Cancer. 2015;87:S49-S50

Link1 Link2

Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma

Stephen Abel, Shaakir Hasan, Richard White, Lana Schumacher, Gene Finley, Athanasios Colonias, Rodney E. Wegner

Lung Cancer. 2019;128:127-133

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.